Abiopharma

🔍 Cook Christopher S (Executive)

Company: Ultra Clean Holdings, Inc. (UCTT)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Sold 1,861 shares of Common Stock at $78.15 per share (Direct)
  Date: 2026-04-30 | Code: F | equity_swap_involved: 0 | shares_owned_after: 128,154.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 4,181 shares of Common Stock at $78.15 per share (Direct)
  Date: 2026-04-30 | Code: F | equity_swap_involved: 0 | shares_owned_after: 123,973.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 3,165 shares of Common Stock at $78.15 per share (Direct)
  Date: 2026-04-30 | Code: F | equity_swap_involved: 0 | shares_owned_after: 120,808.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 11,903 shares of Common Stock at $75.31 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 108,905.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 4,100.00

Footnotes:

• F1: Represents shares automatically withheld for payment of tax liability arising as a result of the partial settlement of restricted stock unit awards that vested.
• F2: This is the weighted average sale price. Shares were sold in multiple transactions at prices from $75.1503 to $75.6900. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).